Search IconSearch

Tumor Oncology

April 20, 2022/Cancer/Tumor Oncology

Combination Chemo-Immunotherapy Appears to Improve Outcomes in Muscle-Invasive Bladder Cancer

New results from the BLASST-1 trial show increases in downstaging and relapse-free survival

Mammary carcinoma with lobular features. Breast cancer
April 12, 2022/Cancer/Tumor Oncology

MRI May Be Best Tool for Tumor Staging and Detecting Bilateral Disease in Invasive Lobular Carcinoma

Study highlights value of preoperative imaging to guide surgical decision-making

July 1, 2021/Cancer/Tumor Oncology

Designing an Optimal Breast Cancer Radiation Protocol

How a novel tissue marker makes a difference


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

June 29, 2021/Cancer/Tumor Oncology

Achieving Cost-Effectiveness with Adjuvant Osimertinib for NSCLC

Model identifies target OS at which economic benefits of treatment outpace placebo

May 24, 2021/Cancer/Tumor Oncology

Combination Maintenance Therapy in Metastatic Urothelial Cancer

In search of improved outcomes for patients

650×450-Prostate-GettyImages-580120508_New Header_17-URL-680
May 12, 2021/Cancer/Tumor Oncology

Innovations in Prostate Cancer Care

An overview of our leading-edge diagnostics and therapeutics

December 9, 2020/Cancer/Tumor Oncology

Invasive Lobular Breast Cancer May Have Worse Prognosis than Ductal Cancer

Multi-institutional registry analysis highlights need for further research

BackPage 1 of 3Next